Eric Song News Today

Brain fog after COVID-19 is biologically similar to cognitive impairment caused by cancer chemotherapy, something doctors often refer to as "chemo brain."

Eyes guard brain; vaccines via eye injections trigger immune response against herpes, offering therapeutic insights

The eyes serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.

Jingle & Mingle for a Jolly Christmas!

Enjoy a nice weekend with events from our editors picks!

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack mutant tumor cells, has transformed the treatment landscape for patients battling cancer, which emerges from the progressive accumulation of DNA mutations.

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack mutant tumor cells, has transformed the treatment landscape for patients battling cancer, which emerges from the progressive accumulation of DNA mutations. However, many patients do not respond to immunotherapy.

Yale researchers have found that a mechanism for faulty DNA repair in tumors is a key factor in determining whether patients respond to immunotherapy.